Kirk Kaminsky is President of U.S. Pharmaceutical for McKesson Corporation. As a member of the Executive Operating Team, Kirk is responsible for providing leadership and strategic direction for McKesson’s best-in-class wholesale drug distribution and value-added technology solutions for retail pharmacies, health systems, payers and community providers in the U.S. Kirk also leads the development of the company’s oncology ecosystem, a strategic growth pillar, through The US Oncology Network, Sarah Cannon Research Institute, Ontada and Biologics by McKesson specialty pharmacy.
Kirk joined McKesson in 2003 and has served in a variety of leadership roles at the company. Most recently, Kirk headed the Specialty Provider Organization, a division of U.S. Pharmaceutical. In addition, he served as President of The US Oncology Network, led the U.S. Pharmaceutical packaging business and was a member of the company’s Corporate Strategy and Business Development function. Prior to joining McKesson, Kirk worked in investment banking as a financial analyst, concentrating on corporate finance for healthcare and consumer retail.
Kirk is the Vice Chair of the Healthcare Distribution Alliance (HDA) Executive Committee and Board of Directors.
Kirk holds a Bachelor of Arts in Economics for Business from Occidental College and a Master of Business Administration from The Wharton School.